Oculis Holding AG (OCS) Other Non-Current Liabilities (2023 - 2026)

Oculis Holding AG's (OCS) quarterly Other Non-Current Liabilities came in at $26.2 million in Q1 2026, up 57.89% year-on-year from $16.6 million in Q1 2025, and up 44.81% quarter-over-quarter from $18.1 million in Q4 2025.

Oculis Holding AG (OCS) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends

Oculis Holding AG's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $26.2 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 57.89% year-over-year to $26.2 million in Q1 2026; TTM through Mar 2026 was $26.2 million, a 57.89% increase from a year earlier, with the FY2025 full-year figure at $17.5 million, down 22.61% from the prior year.
  • Other Non-Current Liabilities advanced to $26.2 million in Q1 2026 per OCS's latest filing, from $18.1 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $26.2 million in Q1 2026 and bottomed at $4.8 million in Q2 2023.
  • The 4-year median for Other Non-Current Liabilities is $12.4 million (2025), against an average of $13.5 million.
  • Across the five-year window, Other Non-Current Liabilities surged 274.31% in 2024 and decreased 20.06% in 2025, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $6.1 million in 2023, then jumped by 274.31% to $22.7 million in 2024, then fell by 20.06% to $18.1 million in 2025, then surged by 44.81% to $26.2 million in 2026.
  • Per Business Quant, the three latest OCS Other Non-Current Liabilities figures stand at $26.2 million (Q1 2026), $18.1 million (Q4 2025), and $15.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 26.23 Mn
Dec 31, 2025 18.11 Mn
Sep 30, 2025 15.18 Mn
Jun 30, 2025 18.25 Mn
Mar 31, 2025 16.61 Mn
Dec 31, 2024 22.66 Mn
Sep 30, 2024 9.01 Mn
Jun 30, 2024 8.14 Mn
Mar 31, 2024 9.67 Mn
Dec 31, 2023 6.05 Mn
Sep 30, 2023 7.45 Mn
Jun 30, 2023 4.78 Mn